Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
暂无分享,去创建一个
[1] R. Lamb,et al. The M2 Proton Channels of Influenza A and B Viruses* , 2006, Journal of Biological Chemistry.
[2] Mai Suan Li,et al. Secondary structure, mechanical stability, and location of transition state of proteins. , 2007, Biophysical journal.
[3] Chin‐Yun Lee,et al. Influenza pandemics: past, present and future. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.
[4] R. Webster,et al. H5N1 influenza--continuing evolution and spread. , 2006, The New England journal of medicine.
[5] Mai Suan Li,et al. Top Leads for Swine Influenza A/H1N1 Virus Revealed by Steered Molecular Dynamics Approach , 2010, J. Chem. Inf. Model..
[6] M. Yamashita,et al. Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration , 2010, Antimicrobial Agents and Chemotherapy.
[7] K. Schulten,et al. Steered molecular dynamics and mechanical functions of proteins. , 2001, Current opinion in structural biology.
[8] Y. Ohashi,et al. Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection , 2010, Antimicrobial Agents and Chemotherapy.
[9] Mai Suan Li,et al. Biomolecules under mechanical force , 2010 .
[10] Tanja Popovic,et al. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[11] A. Monto,et al. Implications of viral resistance to amantadine in control of influenza A. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Yoshihiro Kawaoka,et al. Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses , 2010, PLoS pathogens.
[13] Gabriele Neumann,et al. Emergence and pandemic potential of swine-origin H1N1 influenza virus , 2009, Nature.
[14] C. Fraser,et al. Public Health Risk from the Avian H5N1 Influenza Epidemic , 2004, Science.
[15] P. Kollman,et al. Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate−DNA Helices , 1998 .
[16] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[17] Alan J. Hay,et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants , 2008, Nature.
[18] Alan E. Mark,et al. The GROMOS96 Manual and User Guide , 1996 .
[19] D. M. F. Aalten,et al. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules , 1996, J. Comput. Aided Mol. Des..
[20] Ryo Takano,et al. Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses , 2010, PLoS pathogens.
[21] Abdul-Rahman Allouche,et al. Gabedit—A graphical user interface for computational chemistry softwares , 2011, J. Comput. Chem..
[22] Takanori Tomozawa,et al. CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity , 2008, Antimicrobial Agents and Chemotherapy.
[23] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[24] Hideo Goto,et al. Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.
[25] R. Webster,et al. Pandemic influenza as a current threat. , 2009, Current topics in microbiology and immunology.
[26] A. Cavalli,et al. Single-molecule pulling simulations can discern active from inactive enzyme inhibitors. , 2010, Journal of the American Chemical Society.
[27] A. Moscona. Neuraminidase inhibitors for influenza. , 2005, The New England journal of medicine.
[28] J. Skehel,et al. The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.
[29] P. Palese,et al. Influenza: old and new threats , 2004, Nature Medicine.
[30] I. Stephenson,et al. Chemotherapeutic control of influenza. , 1999, The Journal of antimicrobial chemotherapy.